QurAlis NEWS

CAMBRIDGE, Mass., May 13, 2020— QurAlis Corporation, a biotech company focused on developing precision therapeutics for amyotrophic lateral sclerosis (ALS) and other neurologic diseases, today announced the raise of a…

JOIN US IN THE FIGHT AGAINST ALS

Whether you or a loved one is battling ALS and you want to be a part of our clinical trials, or you want to invest in the fight against this debilitating disease, we want to hear from you. Fill out the form below today and we will get back to you as quickly as possible.

First Name

Last Name

Email

Phone

Message

CAPTCHA

Name

This field is for validation purposes and should be left unchanged.

QurAlis is specifically focused on discovering and developing new therapies for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease.